BioMarin Pharmaceutical Market Cap

BioMarin Pharmaceutical has a market cap or net worth of 8.49 billion as of February 12, 2026. Its market cap has decreased by -12.39% in one year.

Market Cap

8.49B

Enterprise Value

7.85B

Revenue

2.30B

Ranking

n/a

PE Ratio

21.93

Stock Price

61.09

Market Cap Chart

Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 283.77M to 8.49B, an increase of 2,892.56%. That is a compound annual growth rate of 13.64%.

Market Cap History

Date	Market Cap	% Change
Feb 11, 2026	8.49B	0.10%
Dec 31, 2025	8.48B	-15.22%
Dec 31, 2024	10.01B	-29.83%
Dec 29, 2023	14.26B	-10.67%
Dec 30, 2022	15.96B	33.26%
Dec 31, 2021	11.98B	2.74%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	229.82B
GSK plc	86.28B
Haleon	36.19B
Smith & Nephew	10.94B
Convatec Group	4.29B
Hikma Pharmaceuticals	3.44B
Genus	2.06B
HUTCHMED (China)	1.88B

Market Cap Rankings